NTRA News and Press, Natera Inc. From 06/02/23

2023-06-02 01:29:17 ET Summary Duquesne Family Office's 13F portfolio value increased by 14% to $2.31B in Q1 2023, with 29 securities significantly large. Microsoft, Alphabet, Amazon, IQVIA Holdings, News Corp, and Taiwan Semi were among the new stakes established during the quart...

Highlights include oral presentations in Sarcoma and CRC; immunotherapy monitoring data from the Phase 3 EMPOWER-Lung 1 study; updates from the CIRCULATE-Japan study in CRC Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that new data on its pe...

2023-05-19 11:54:31 ET Summary Natera reported outstanding Q1 2023 financial results, with revenues soaring to $241.8 million, marking a 24.5% increase from the same period in 2022. The company's product revenues witnessed a dramatic 25.2% growth due to increased test volumes, han...

2023-05-17 12:37:04 ET Summary Today, we revisit genetic testing concern Natera, Inc., as the shares are up more than 30% so far in 2023. The company continues to deliver solid revenue growth even as its cash burn rate remains a concern. Which way do Natera, Inc. shares go fro...

2023-05-15 16:59:32 ET Invitae ( NYSE: NVTA ) said it will appeal a verdict in a patent case in a federal court in Delaware that found in favor of Natera ( NTRA ). Invitae ( NVTA ) has been ordered to pay $19.35M for infringing some Natera ( NTRA ) patents. The...

Natera has a broad, global IP portfolio of more than 360 issued or pending patents, with more than 180 in the field of oncology/MRD Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that a jury in the U.S. District Court for the District of Delaw...

2023-05-09 23:07:08 ET Natera, Inc. (NTRA) Q1 2023 Earnings Conference Call May 09, 2023, 04:30 PM ET Company Participants Steven Chapman - Chief Executive Officer Michael Brophy - Chief Financial Officer Alexey Aleshin - Chief Medical Officer John Fesko - Ch...

2023-05-09 16:25:19 ET Natera press release ( NASDAQ: NTRA ): Q1 GAAP EPS of -$1.23 misses by $0.07 . Revenue of $241.8M (+24.6% Y/Y) beats by $14.37M . Raising 2023 annual revenue guidance from $990 million to $1.0 billion to a new range of $995 million to $1....

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today reported financial results for the first quarter ended March 31, 2023. Recent Strategic and Financial Highlights Generated total revenues of $241.8 million in the first quarter of 2023, compared to $194.1 m...

2023-05-08 17:35:56 ET Major earnings expected after the bell on Tuesday include: Airbnb ( ABNB ) Occidental Petroleum Corporation ( OXY ) Twilio ( TWLO ) Virgin Galactic Holdings ( SPCE ) Upstart Holdings ( UPST ) For further details see: ...